Northern Trust
ALBO

Northern Trust’s Albireo Pharma Inc ALBO Stock Holding History

Northern Trust’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-183,902
Closed -$3.97M – 4666
2022
Q4 		$3.97M Buy
183,902
+6,884
+4% +$145K ﹤0.01% 2621
2022
Q3 		$3.43M Sell
177,018
-4,414
-2% -$91.3K ﹤0.01% 2717
2022
Q2 		$3.6M Sell
181,432
-3,145
-2% -$83K ﹤0.01% 2717
2022
Q1 		$5.51M Sell
184,577
-5,868
-3% -$172K ﹤0.01% 2532
2021
Q4 		$4.44M Sell
190,445
-4,486
-2% -$119K ﹤0.01% 2762
2021
Q3 		$6.08M Sell
194,931
-4,027
-2% -$125K ﹤0.01% 2611
2021
Q2 		$7M Sell
198,958
-7,409
-4% -$241K ﹤0.01% 2615
2021
Q1 		$7.27M Sell
206,367
-19,972
-9% -$737K ﹤0.01% 2505
2020
Q4 		$8.49M Buy
226,339
+30,659
+16% +$1.11M ﹤0.01% 2357
2020
Q3 		$6.53M Sell
195,680
-2,425
-1% -$70.6K ﹤0.01% 2372
2020
Q2 		$5.25M Buy
198,105
+22,501
+13% +$531K ﹤0.01% 2490
2020
Q1 		$2.87M Buy
175,604
+25,913
+17% +$570K ﹤0.01% 2641
2019
Q4 		$3.81M Buy
149,691
+42
+0% +$840 ﹤0.01% 2752
2019
Q3 		$2.99M Buy
149,649
+29,756
+25% +$770K ﹤0.01% 2862
2019
Q2 		$3.87M Buy
119,893
+2,631
+2% +$88K ﹤0.01% 2690
2019
Q1 		$3.78M Buy
117,262
+3,569
+3% +$96.1K ﹤0.01% 2713
2018
Q4 		$2.79M Sell
113,693
-26
-0% -$687 ﹤0.01% 2867
2018
Q3 		$3.75M Buy
113,719
+13,900
+14% +$455K ﹤0.01% 2867
2018
Q2 		$3.54M Buy
99,819
+84,053
+533% +$2.72M ﹤0.01% 2879
2018
Q1 		$513K Buy
15,766
+5,932
+60% +$200K ﹤0.01% 3561
2017
Q4 		$252K Buy
+9,834
New +$249K ﹤0.01% 3737
2017
Q3 		– Sell
-9,886
Closed -$204K – 4283
2017
Q2 		$204K Buy
+9,886
New +$203K ﹤0.01% 3792
2016
Q4 		– Sell
-1,525
Closed -$20K – 4216
2016
Q3 		$20K Hold
1,525
– – ﹤0.01% 4105
2016
Q2 		$14K Hold
1,525
– – ﹤0.01% 4140
2016
Q1 		$15K Hold
1,525
– – ﹤0.01% 4151
2015
Q4 		$16K Hold
1,525
– – ﹤0.01% 4187
2015
Q3 		$20K Buy
1,525
+325
+27% +$8.19K ﹤0.01% 4182
2015
Q2 		$37K Buy
1,200
+380
+46% +$12.8K ﹤0.01% 4099
2015
Q1 		$29K Sell
820
-18
-2% -$759 ﹤0.01% 4204
2014
Q4 		$34K Sell
838
-1
-0.1% -$44 ﹤0.01% 4140
2014
Q3 		$42K Buy
839
+1
+0.1% +$57 ﹤0.01% 4163
2014
Q2 		$54K Sell
838
-1
-0.1% -$70 ﹤0.01% 4103
2014
Q1 		$68K Buy
839
+322
+62% +$29.3K ﹤0.01% 4013
2013
Q4 		$35K Sell
517
-11
-2% -$806 ﹤0.01% 4000
2013
Q3 		$50K Buy
528
+82
+18% +$10.7K ﹤0.01% 3939
2013
Q2 		$56K Buy
+446
New +$46.4K ﹤0.01% 3912

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northern Trust's ALBO Position: Q1 2023 in Review

Northern Trust sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 183,902 shares — an estimated $3.97M sold.

Northern Trust first reported a position in ALBO in Q2 2013 and held it in 36 quarters. The position peaked at $8.49M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Northern Trust reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 183,902 Albireo Pharma Inc shares in Q1 2023, an estimated $3.97M.
  • Northern Trust first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 36 quarters.
  • Northern Trust's Albireo Pharma Inc position peaked at $8.49M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.